Fny Investment Advisers, LLC Bridge Bio Pharma, Inc. Transaction History
Fny Investment Advisers, LLC
- $164 Million
- Q1 2025
A detailed history of Fny Investment Advisers, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 11,336 shares of BBIO stock, worth $377,942. This represents 0.24% of its overall portfolio holdings.
Number of Shares
11,336
Previous 13,750
17.56%
Holding current value
$377,942
Previous $377,000
3.71%
% of portfolio
0.24%
Previous 0.19%
Shares
8 transactions
Others Institutions Holding BBIO
# of Institutions
361Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$735 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$642 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$497 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$415 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$239 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.94B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...